• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

SpePharm

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · September 1, 2011

SpePharm Sells Japanese Rights for Savene® to Kissei Pharmaceutical

Amsterdam, 1st September 2011 - SpePharm Holding B.V.(Amsterdam, The Netherlands), the pan-European specialty pharmaceutical company, today announced that it has sold the Japanese rights to Savene® to …

News · May 31, 2011

The Paris Court of Appeals rejects the appeals lodged by BioAlliance Pharma in a case against Spepharm Holding B.V. and SpeBio BV, and orders BioAlliance Pharma to refund in total € 500K of legal costs to the two companies.

Amsterdam, May 31, 2011. SpePharm Holding B.V. announces that the appeals lodged by BioAlliance Pharma S.A. – a French company listed on Paris Euronext – before the Paris Court of Appeals have been …

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact